Home Featured Page 284

Featured

Latest

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

So, You Want to Take Ibogaine: Here’s What You Need to...

Red Light Holland Announces Closing of $11.6 Million Bought Deal Financing

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences

Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation...

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase...

Beckley Psytech appoints ex-pharma CEO as Chief Operating Officer

Catching Up With the Psychedelic Entourage Effect: Part 5 – MindMed

The Psychedelic Entourage Effect: Part 6 – The State of the...

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry...

1...283284285...301 Page 284 of 301

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

So, You Want to Take Ibogaine: Here’s What You Need to...

Red Light Holland Announces Closing of $11.6 Million Bought Deal Financing

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences

Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation...

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase...

Beckley Psytech appoints ex-pharma CEO as Chief Operating Officer

Catching Up With the Psychedelic Entourage Effect: Part 5 – MindMed

The Psychedelic Entourage Effect: Part 6 – The State of the...

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry...

EDITOR PICKS

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY